NCT02715284
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02715284
Title A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors (GARNET)
Acronym GARNET
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tesaro, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | GBR | FRA | ESP | DNK | CZE | CAN | BRA | ARG

Facility Status City State Zip Country Details
GSK Investigational Site Birmingham Alabama 35233 United States Details
GSK Investigational Site Goodyear Arizona 85338 United States Details
GSK Investigational Site Scottsdale Arizona 85258 United States Details
GSK Investigational Site Fayetteville Arkansas 72703 United States Details
GSK Investigational Site Encinitas California 92024 United States Details
GSK Investigational Site La Jolla California 92093 United States Details
GSK Investigational Site Los Angeles California 90095 United States Details
GSK Investigational Site Newport Beach California 92663 United States Details
GSK Investigational Site San Francisco California 94115 United States Details
GSK Investigational Site San Marcos California 92069 United States Details
GSK Investigational Site Santa Monica California 90403 United States Details
GSK Investigational Site Washington D.C. District of Columbia 20007 United States Details
GSK Investigational Site Miami Florida 33136 United States Details
GSK Investigational Site Tampa Florida 33612 United States Details
GSK Investigational Site Augusta Georgia 30912 United States Details
GSK Investigational Site Chicago Illinois 60637 United States Details
GSK Investigational Site Fairway Kansas 66205 United States Details
GSK Investigational Site Scarborough Maine 04074 United States Details
GSK Investigational Site Baltimore Maryland 21231 United States Details
GSK Investigational Site Boston Massachusetts 02114 United States Details
GSK Investigational Site Boston Massachusetts 02215 United States Details
GSK Investigational Site Detroit Michigan 48201 United States Details
GSK Investigational Site Kansas City Missouri 64111 United States Details
GSK Investigational Site Farmington New Mexico 87401 United States Details
GSK Investigational Site Albany New York 12208 United States Details
GSK Investigational Site Brooklyn New York 11203 United States Details
GSK Investigational Site Jamaica New York 11432 United States Details
GSK Investigational Site New York New York 10016 United States Details
GSK Investigational Site Charlotte North Carolina 28204 United States Details
GSK Investigational Site Cleveland Ohio 44106 United States Details
GSK Investigational Site Columbus Ohio 43210 United States Details
GSK Investigational Site Hilliard Ohio 43026 United States Details
GSK Investigational Site Hilliard Ohio 43210 United States Details
GSK Investigational Site Oklahoma City Oklahoma 73104 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19104 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19111 United States Details
GSK Investigational Site Providence Rhode Island 02905 United States Details
GSK Investigational Site Dallas Texas 75230 United States Details
GSK Investigational Site Dallas Texas 75290-9032 United States Details
GSK Investigational Site San Antonio Texas 78229 United States Details
GSK Investigational Site Salt Lake City Utah 84112 United States Details
GSK Investigational Site Charlottesville Virginia 22903 United States Details
GSK Investigational Site Seattle Washington 98104 United States Details
GSK Investigational Site Seattle Washington 98195 United States Details
GSK Investigational Site Spokane Washington 99202 United States Details
GSK Investigational Site Spokane Washington 99204 United States Details
GSK Investigational Site Milwaukee Wisconsin 53226 United States Details
GSK Investigational Site Ciudad Autonoma de Buenos Aire C1280AEB Argentina Details
GSK Investigational Site Córdoba X5000HXL Argentina Details
GSK Investigational Site Córdoba X5004FHP Argentina Details
GSK Investigational Site Barretos 14784-400 Brazil Details
GSK Investigational Site Porto Alegre 90035-000 Brazil Details
GSK Investigational Site Ribeirão Preto 14040-030 Brazil Details
GSK Investigational Site Rio de Janeiro 20231-050 Brazil Details
GSK Investigational Site São José do Rio Preto 15090-200 Brazil Details
GSK Investigational Site São Paulo 01246-000 Brazil Details
GSK Investigational Site São Paulo 01308-901 Brazil Details
GSK Investigational Site São Paulo 01321-001 Brazil Details
GSK Investigational Site Calgary Alberta T2N 4N2 Canada Details
GSK Investigational Site Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site Kelowna British Columbia V1Y 5L3 Canada Details
GSK Investigational Site Vancouver British Columbia V5Z 4E6 Canada Details
GSK Investigational Site Hamilton Ontario L8V 5C2 Canada Details
GSK Investigational Site London Ontario N6A 4L6 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Montreal Quebec H2L 4M1 Canada Details
GSK Investigational Site Montreal Quebec H4A 3J1 Canada Details
GSK Investigational Site Hořovice 26831 Czechia Details
GSK Investigational Site Zlín 762 75 Czechia Details
GSK Investigational Site Copenhagen DK- 2100 Denmark Details
GSK Investigational Site Odense C 5000 Denmark Details
GSK Investigational Site Bordeaux 33076 France Details
GSK Investigational Site Caen 14076 France Details
GSK Investigational Site Lille 59000 France Details
GSK Investigational Site Marseille 13273 France Details
GSK Investigational Site Paris 75571 France Details
GSK Investigational Site Paris 75908 France Details
GSK Investigational Site Saint-Herblain 44805 France Details
GSK Investigational Site Villejuif 94805 France Details
GSK Investigational Site Milan 20132 Italy Details
GSK Investigational Site Milan 20133 Italy Details
GSK Investigational Site Milan 20141 Italy Details
GSK Investigational Site Modena 41100 Italy Details
GSK Investigational Site Naples 80131 Italy Details
GSK Investigational Site Roma 00144 Italy Details
GSK Investigational Site Verona 37134 Italy Details
GSK Investigational Site Monterrey 66278 Mexico Details
GSK Investigational Site Gdynia 81-519 Poland Details
GSK Investigational Site Lublin 20-090 Poland Details
GSK Investigational Site Olsztyn 10-513 Poland Details
GSK Investigational Site Olsztyn 10-561 Poland Details
GSK Investigational Site Torun 87-100 Poland Details
GSK Investigational Site Warsaw 02-781 Poland Details
GSK Investigational Site Gwangju 61469 South Korea Details
GSK Investigational Site Seongnam-si 463-712 South Korea Details
GSK Investigational Site Seongnam-si Gyeonggi-do 463 707 South Korea Details
GSK Investigational Site Seoul 02841 South Korea Details
GSK Investigational Site Seoul 05505 South Korea Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Barcelona 08907 Spain Details
GSK Investigational Site Barcelona 8035 Spain Details
GSK Investigational Site Girona 08907 Spain Details
GSK Investigational Site Girona 17007 Spain Details
GSK Investigational Site Madrid 28027 Spain Details
GSK Investigational Site Madrid 28040 Spain Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site Madrid 28050 Spain Details
GSK Investigational Site Málaga 29010 Spain Details
GSK Investigational Site Murcia 30120 Spain Details
GSK Investigational Site Pamplona 31008 Spain Details
GSK Investigational Site Santander 39008 Spain Details
GSK Investigational Site Santiago de Compostela 15706 Spain Details
GSK Investigational Site Seville 41013 Spain Details
GSK Investigational Site Valencia 46009 Spain Details
GSK Investigational Site Valencia 46010 Spain Details
GSK Investigational Site Zaragoza 50009 Spain Details
GSK Investigational Site Aberdeen AB25 2ZN United Kingdom Details
GSK Investigational Site London SE1 9RT United Kingdom Details
GSK Investigational Site London SW3 6JJ United Kingdom Details
GSK Investigational Site London W1G 6AD United Kingdom Details
GSK Investigational Site London W1T 7HA United Kingdom Details
GSK Investigational Site Manchester M20 4BX United Kingdom Details
GSK Investigational Site Newcastle upon Tyne NE7 7DN United Kingdom Details
GSK Investigational Site Oxford OX3 7LE United Kingdom Details
GSK Investigational Site Sutton SW36JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field